Language Selection

Get healthy now with MedBeds!
Click here to book your session

Protect your whole family with Orgo-Life® Quantum MedBed Energy Technology® devices.

Advertising by Adpathway

         

 Advertising by Adpathway

TYMP Enzyme Promotes Aggressive Synovial Cell Growth in Rheumatoid Arthritis

2 days ago 11

PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY

Orgo-Life the new way to the future

  Advertising by Adpathway

Elevated expression of thymidine phosphorylase (TYMP) contributes directly to the aggressive behavior of fibroblast-like synoviocytes in rheumatoid arthritis by upregulating autophagy through a hypoxia-inducible factor 1-alpha and reactive oxygen species pathway, according to findings published in Cell Biology and Toxicology. Researchers established that targeting this molecular axis can suppress pathological cellular activity in laboratory models.

Rheumatoid arthritis is a chronic systemic autoimmune disease characterized by the heightened proliferation, migration, and invasion of fibroblast-like synoviocytes (FLS) within joint synovial tissue. Thymidine phosphorylase, which is also identified as platelet-derived endothelial cell growth factor (PD-ECGF), is known to participate in cellular proliferation and angiogenesis. Although elevated levels of this enzyme had previously been detected in patients suffering from rheumatoid arthritis, its specific functional contribution and underlying mechanism in synovial cells had remained unresolved.

To clarify how the enzyme acts in the disease process, the investigative team analyzed TYMP expression profiles across synovial tissue samples gathered from human rheumatoid arthritis patients and collagen-induced arthritis (CIA) model mice. Quantitative assessments revealed that TYMP expression was significantly increased in rheumatoid arthritis synovial tissue as well as in isolated patient-derived synoviocytes when compared directly against non-arthritic control tissues.

Following the identification of increased expression, researchers conducted comprehensive gain-of-function and loss-of-function laboratory experiments in cultured rheumatoid arthritis fibroblast-like synoviocytes. These functional assays demonstrated that TYMP actively promoted cell proliferation, migration, and tissue invasion. Modulating the enzyme confirmed that elevated cellular levels drove aggressive synoviocyte activities that closely mirror the invasive cellular characteristics observed in rheumatoid joint destruction.

At the biochemical level, experimental modulation revealed that TYMP heightened intracellular reactive oxygen species (ROS) production and upregulated specific autophagy-related proteins, including Beclin-1, p62, and LC3BII. The investigation determined that this induction of autophagy operated through a hypoxia-inducible factor 1-alpha (HIF-1α)-dependent pathway. Silencing TYMP in synovial cells successfully suppressed ROS generation, impeded the activation of autophagy, and reversed aggressive cellular traits, whereas overexpressing TYMP led to opposite outcomes.

The therapeutic potential of inhibiting this pathway was evaluated in vivo using mice with collagen-induced arthritis. Pharmacological inhibition of TYMP in the arthritic mouse model led to measurable reductions in synovial tissue inflammation, decreased joint hyperplasia, and lowered the expression of autophagy markers. These animal observations provided experimental evidence that systemic suppression of the enzyme attenuates core pathological features within diseased synovial joints.

Based on these in vitro and in vivo findings, the authors concluded that elevated TYMP expression sustains the destructive phenotype of synovial cells by stimulating HIF-1α- and ROS-mediated autophagy. The researchers proposed that therapeutic interventions directed at the TYMP-HIF-1α signaling axis to modulate reactive oxygen species and associated autophagy pathways represent a promising future strategy for treating rheumatoid arthritis.

Subject of Research: Mechanism of TYMP-driven autophagy and aggressive synoviocyte behavior in rheumatoid arthritis

Article Title: TYMP promotes aggressive behavior of fibroblast-like synoviocyte in rheumatoid arthritis by upregulating autophagy through HIF-1α/ROS pathway

Article References: Shao, J., Zhang, Y., Tan, Q., Zhang, S., Zhu, Y., Yin, Z., Du, H., & Jie, L. (2026). TYMP promotes aggressive behavior of fibroblast-like synoviocyte in rheumatoid arthritis by upregulating autophagy through HIF-1α/ROS pathway. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-026-10329-2

Image Credits: AI Generated

DOI: 10.1007/s10565-026-10329-2

Keywords: rheumatoid arthritis, thymidine phosphorylase, TYMP, fibroblast-like synoviocytes, RA FLS, platelet-derived endothelial cell growth factor, PD-ECGF, autophagy, HIF-1alpha, reactive oxygen species, ROS production, Beclin-1, p62, LC3BII, collagen-induced arthritis, synovial hyperplasia, synovial inflammation

Read Entire Article

         

        

Start the new Vibrations with a Medbed Franchise today!  

Protect your whole family with Quantum Orgo-Life® devices

  Advertising by Adpathway